Evolent Health, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
Key Highlights
- Share count: As of October 30, 2026, there were 113,105,519 shares of Class A common stock outstanding.
- Filer classification: The company is classified as a large accelerated filer, according to the filing.
- Exchange listing: Class A Common Stock trades on the New York Stock Exchange under the symbol EVH (NYSE:EVH).
- Debt reduction intention: The filing references the company's stated intention "to deploy up to $50 million toward reducing outstanding indebtedness by the end of the year," characterizing this as a forward-looking statement subject to its cautionary language.
- Operating structure: Evolent Health, Inc. is described as a holding company whose principal asset is all of the Class A common units of subsidiary Evolent Health LLC, through which the company conducts its operations.
- Principal offices: The registrant's address is 1812 N. Moore Street, Suite 1705, Arlington, Virginia 22209.
Evolent Health's September 2026 Quarterly Disclosure: Structure, Shares, and Key Risk Factors
Evolent Health, Inc. (NYSE:EVH) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the Commission File Number 001-37415. The filing identifies Evolent Health, Inc. as a Delaware-incorporated holding company whose operations are conducted through its subsidiary, Evolent Health LLC, which the filing states "has owned all of our operating assets and substantially all of our business since inception."
According to the filing, as of October 30, 2026, there were 113,105,519 shares of Class A common stock outstanding, with a par value of $0.01 per share. The company confirmed it has filed all required reports during the preceding 12 months and has submitted all required Interactive Data Files electronically, as indicated by the affirmative check marks on the filing's cover page.
The filing includes an extensive forward-looking statements section, which the company states is protected by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Among the forward-looking items cited, the filing references "our intention to deploy up to $50 million toward reducing outstanding indebtedness by the end of the year." The cautionary language enumerates numerous risk factors, including revenue concentration among largest partners, risks related to performance-based contracts, regulatory and political evolution in healthcare, data security and privacy risks, risks associated with artificial intelligence and machine learning models, and obligations under a tax receivables agreement, among others.
What Was Disclosed
Evolent Health filed a Form 10-Q for the quarter ended September 30, 2026, disclosing 113,105,519 Class A shares outstanding as of October 30, 2026, its large accelerated filer status, its holding-company structure, and a range of forward-looking statements and associated risk factors.






Please wait processing your request...